Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Two phase I trials of AP-23573 begin

May 9, 2003

Enrollment resumes in phase I Reolysin study

May 9, 2003

Novel inhibitors of VEGFR, PDGFR and/or c-kit kinase under study at Sugen

May 9, 2003

CDK inhibitors in early development at Bayer

May 9, 2003

Schering and Pharmacopeia present new CXC antagonists for cancer and other uses

May 9, 2003

Polycyclic antitumor compounds newly discovered at Roche

May 9, 2003

Schering AG and Astex enter drug discovery collaboration

May 8, 2003

Updated phase II results for Tocosol Paclitaxel

May 8, 2003

Progress made in Bexxar review

May 8, 2003

Introgen gains license to fus1 anticancer gene

May 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...